BlackRock Investment Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$428K Hold
26,397
﹤0.01% 3085
2016
Q3
$356K Sell
26,397
-63
-0.2% -$1.29K ﹤0.01% 3143
2016
Q2
$646K Buy
26,460
+1,079
+4% +$36.4K ﹤0.01% 2917
2016
Q1
$877K Buy
+25,381
New +$667K ﹤0.01% 2573

Other funds holding EDIT

BlackRock Investment Management's EDIT Position: Q4 2016 in Review

BlackRock Investment Management held its Editas Medicine (EDIT) position steady in Q4 2016 at 26,397 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

BlackRock Investment Management first reported a position in EDIT in Q1 2016 and has held it in 4 quarters since. The position peaked at $877K in Q1 2016. 84 funds tracked by Wall St. Rank hold EDIT as of Q4 2016.

  • BlackRock Investment Management held 26,397 shares of Editas Medicine worth $428K as of Q4 2016.
  • BlackRock Investment Management left its Editas Medicine share count unchanged in Q4 2016.
  • Editas Medicine made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3085 holding.
  • BlackRock Investment Management first reported a position in Editas Medicine in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Investment Management's Editas Medicine position peaked at $877K in Q1 2016.
  • 84 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.